Profil
Graham George Lumsden is currently the President & Chief Executive Officer at BioMarck Pharmaceuticals Ltd. and a Member at the Royal College of Veterinary Surgeons.
He previously served as the Chief Executive Officer & Executive Director at Motif BioSciences, Inc., Chief Executive Officer at Tiemed LLC, Director at Immutep Ltd., Non-Executive Director at Motif Bio Plc, and Principal at Merck & Co., Inc. and Carnethy Consulting LLC.
Lumsden received his undergraduate degree from The Royal School of Veterinary Studies in 1982.
Aktive Positionen von Graham Lumsden
| Unternehmen | Position | Beginn |
|---|---|---|
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Corporate Officer/Principal | - |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Vorstandsvorsitzender | 05.01.2021 |
Ehemalige bekannte Positionen von Graham Lumsden
| Unternehmen | Position | Ende |
|---|---|---|
| MOTIF BIO PLC | Vorstandsvorsitzender | 04.05.2020 |
Tiemed LLC | Vorstandsvorsitzender | 01.01.2014 |
Carnethy Consulting LLC | Corporate Officer/Principal | 01.01.2014 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01.01.2001 |
| IMMUTEP LIMITED | Direktor/Vorstandsmitglied | - |
Ausbildung von Graham Lumsden
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antibiotics for life-threatening infections | Health Technology |
BioMarck Pharmaceuticals Ltd.
BioMarck Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new drugs for the treatment of pulmonary diseases and disorders | Health Technology |
Royal College of Veterinary Surgeons
Royal College of Veterinary Surgeons Miscellaneous Commercial ServicesCommercial Services Functions as the regulatory body for veterinary surgeons in the United Kingdom | Commercial Services |
Immutep Ltd.
Immutep Ltd. BiotechnologyHealth Technology Engages in the development of anti-cancer therapeutics | Health Technology |
Motif Bio Plc
Motif Bio Plc Pharmaceuticals: MajorHealth Technology Develops antibiotics designed to be effective against serious and life-threatening infections | Health Technology |
Tiemed LLC | |
Carnethy Consulting LLC | |
The Royal School of Veterinary Studies
The Royal School of Veterinary Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















